Why Rocket Lab Stock Is Plummeting Today

Rocket Lab shares fell 7.9% (down as much as 11% earlier) as bearish sentiment around AI stock valuations spilled into growth-exposed names. The article cites AI-related pressure from DeepSeek developing AI chips to compete with Nvidia and investors questioning Samsung’s aggressive spending despite strong results. It also points to renewed Middle East geopolitical risk (Iran strikes on oil tankers) and uncertainty around Trump/NATO comments as additional volatility drivers.

Analysis

RKLB is behaving like a duration asset, not a standalone space name: when the market de-risks long-multiple growth, the weakest balance sheets and least-proven cash generators get sold first regardless of business line. Over the next few sessions, the stock’s path will likely be dictated more by QQQ/NVDA stabilization than by any company-specific development, so the tape can overshoot fundamentals both ways.

The second-order winner set is less obvious than “defense gets bid.” Cash-generative aerospace/defense names and broad quality growth should absorb some of the rotated capital, while the most crowded speculative clusters in small-cap tech, space, and other pre-profit narratives can see multiple compression even if their operating outlook is unchanged. If geopolitical stress persists, that is not a clean positive for RKLB; capital tends to prefer backlog, free cash flow, and balance-sheet resilience over optionality when volatility rises.

Contrarian view: this may be mostly flow-driven unless we see evidence that financing conditions or launch/contract execution are deteriorating. If RKLB can hold up while NVDA and broader growth stay weak, that would argue the selloff was overdone and driven by forced de-risking. Falsifiers for the bearish read are a reclaim of pre-selloff VWAP on volume or a rapid market-wide risk-on reversal after the next macro catalyst.

Key Decisions for Investors

• Do not add fresh longs in RKLB until the stock reclaims its pre-selloff VWAP / 20-day moving average; in this tape, catch-the-falling-knife risk outweighs near-term upside.
• For 1-3 month relative value, consider long LMT or RTX vs short RKLB: if growth multiples keep compressing, RKLB should underperform while defense names should remain better supported by cash flow and geopolitical bid.
• If already long RKLB, hedge beta with a partial short in QQQ or a broader small-cap growth proxy rather than selling the core immediately; the near-term driver is market correlation, not fundamental impairment.
• Watch NVDA and QQQ into the next risk event: a stabilization there is the cleanest signal to cover bearish momentum shorts in RKLB; a further leg lower would argue for staying defensive.